Year archive

CHIMERIC THERAPEUTICS LIMITED — 2024 filings

All 103 regulatory filings released by CHIMERIC THERAPEUTICS LIMITED (CHM) in 2024, sourced directly from the official regulator.

103 Filings

2024 Period

2024 filings (103)

Filing	Released	Lang
Notification regarding unquoted securities - CHM 7 pages 21.8KB Share Issue/Capital Change	2024-12-22	English
Notification of cessation of securities - CHM 4 pages 14.9KB Regulatory Filings	2024-12-22	English
Notification regarding unquoted securities - CHM 6 pages 18.5KB Share Issue/Capital Change	2024-12-22	English
Phase 1B CHM CORE-NK trial advances to newly diagnosed AML 2 pages 231.1KB Capital/Financing Update	2024-12-15	English
Notification regarding unquoted securities - CHM 6 pages 20.4KB Share Issue/Capital Change	2024-12-12	English
Change of Director's Interest Notice PH 3 pages 236.6KB Director's Dealing	2024-12-12	English
Change in substantial holding - PH 3 pages 264.4KB Major Shareholding Notification	2024-12-10	English
Notification regarding unquoted securities - CHM 6 pages 18.4KB Share Issue/Capital Change	2024-12-09	English
Application for quotation of securities - CHM 6 pages 18.5KB Share Issue/Capital Change	2024-12-09	English
Notice under section 708A 1 page 219.1KB Capital/Financing Update	2024-12-09	English
Update - Notification regarding unquoted securities - CHM 6 pages 18.5KB Share Issue/Capital Change	2024-12-09	English
Application for quotation of securities - CHM 6 pages 18.5KB Capital/Financing Update	2024-12-08	English
Notice under section 708A 1 page 219.9KB Capital/Financing Update	2024-12-08	English
Presentation to Extraordinary General Meeting 11 pages 4.9MB Investor Presentation	2024-12-03	English
Results of Meeting 2 pages 238.4KB Declaration of Voting Results & Voting Rights Announcements	2024-12-03	English
Chimeric receives $4.17m R&D tax incentive 2 pages 184.5KB Regulatory Filings	2024-11-27	English
Constitution 56 pages 1.0MB Governance Information	2024-11-13	English
AGM Presentation and CEO Appointment 15 pages 11.2MB AGM Information	2024-11-11	English
Results of Meeting 2 pages 295.8KB Declaration of Voting Results & Voting Rights Announcements	2024-11-11	English
Notice of Extraordinary General Meeting December 2024 21 pages 476.3KB AGM Information	2024-11-04	English
Application for quotation of securities - CHM 6 pages 18.5KB Share Issue/Capital Change	2024-11-04	English
Notice under section 708A 1 page 219.3KB Capital/Financing Update	2024-11-04	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 995.2KB Interim / Quarterly Report	2024-10-29	English
Application for quotation of securities - CHM 6 pages 18.3KB Capital/Financing Update	2024-10-23	English
Dose finding complete in ADVENT-AML Phase 1b clinical trial 3 pages 214.9KB Regulatory Filings	2024-10-23	English
Investor webinar 2 pages 185.3KB Capital/Financing Update	2024-10-23	English
Prospectus 49 pages 883.7KB Capital/Financing Update	2024-10-22	English
$5 million Placement to progress CHM CDH17 trial 4 pages 245.2KB Capital/Financing Update	2024-10-20	English
Proposed issue of securities - CHM 5 pages 17.7KB Capital/Financing Update	2024-10-20	English
Proposed issue of securities - CHM 7 pages 24.8KB Capital/Financing Update	2024-10-20	English
Annual Report 2024 106 pages 2.6MB Annual Report	2024-10-20	English
Corporate Governance Statement and Appendix 4G 19 pages 580.7KB Governance Information	2024-10-20	English
ESG Report 10 pages 457.1KB Environmental & Social Information	2024-10-20	English
Reinstatement to Official Quotation 1 page 423.6KB Report Publication Announcement	2024-10-20	English
Change in substantial holding - PH 4 pages 389.1KB Major Shareholding Notification	2024-10-15	English
Notice of Annual General Meeting 41 pages 752.3KB AGM Information	2024-10-13	English
2024 Annual Report update 2 pages 178.7KB Report Publication Announcement	2024-10-10	English
AML patient achieves Complete Response in CHM CORE-NK trial 8 pages 346.7KB Regulatory Filings	2024-10-06	English
2024 Annual Report update 1 page 170.8KB Report Publication Announcement	2024-10-03	English
Suspension from Quotation 2 pages 450.1KB Regulatory Filings	2024-09-30	English
Achieve Clinics collaboration to expand reach of CHM CDH17 3 pages 226.2KB Regulatory Filings	2024-09-24	English
Application for quotation of securities - CHM 6 pages 18.5KB Share Issue/Capital Change	2024-09-19	English
Notice under section 708A 1 page 219.2KB Capital/Financing Update	2024-09-19	English
University of Pennsylvania joins CHM CDH17 Phase 1/2 trial 2 pages 212.4KB Regulatory Filings	2024-09-10	English
Appendix 4E and Preliminary Final Report 38 pages 1.1MB Annual Report	2024-08-29	English
Application for quotation of securities - CHM 8 pages 24.4KB Share Issue/Capital Change	2024-08-29	English
Notification regarding unquoted securities - CHM 6 pages 19.3KB Share Issue/Capital Change	2024-08-29	English
Notice under section 708A 1 page 219.9KB Share Issue/Capital Change	2024-08-29	English
First patient dosed in Phase 1/2 trial of CHM CDH17 3 pages 213.3KB Regulatory Filings	2024-08-27	English
Phase 1/2 CHM CDH17 CAR-T GMP Manufacturing Complete 2 pages 210.0KB Regulatory Filings	2024-08-15	English
Chimeric receives $1.5 M advance on FY24 R&D tax incentive 2 pages 202.4KB Capital/Financing Update	2024-08-12	English
Chimeric partnering with Cell Therapies Australia 2 pages 203.9KB Regulatory Filings	2024-08-08	English
Application for quotation of securities - CHM 6 pages 18.5KB Share Issue/Capital Change	2024-08-01	English
Notice under section 708A 1 page 215.6KB Share Issue/Capital Change	2024-08-01	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 929.8KB Interim / Quarterly Report	2024-07-30	English
Investor Presentation 42 pages 5.5MB Investor Presentation	2024-07-24	English
First patient enrolled in CHM CDH17 Phase 1/2 clinical trial 2 pages 189.5KB Regulatory Filings	2024-07-21	English
Application for quotation of securities - CHM 6 pages 18.5KB Share Issue/Capital Change	2024-06-27	English
Notice under section 708A 1 page 215.1KB Regulatory Filings	2024-06-27	English
Notification of cessation of securities - CHM 4 pages 15.4KB Regulatory Filings	2024-06-25	English
Presentation to Extraordinary General Meeting 19 pages 1.5MB Investor Presentation	2024-06-10	English
Results of Meeting 2 pages 270.8KB Declaration of Voting Results & Voting Rights Announcements	2024-06-10	English
Phase 1b ADVENT-AML trial of CHM CORE-NK advances at MDA 3 pages 206.9KB Regulatory Filings	2024-06-04	English
Application for quotation of securities - CHM 6 pages 18.7KB Capital/Financing Update	2024-05-29	English
Notice under section 708A 1 page 215.8KB Regulatory Filings	2024-05-29	English
Final Director's Interest Notice 2 pages 256.2KB Director's Dealing	2024-05-29	English
Chimeric opens CHM CDH17 Phase 1/2 trial 3 pages 208.4KB Regulatory Filings	2024-05-21	English
CHM CDH17 Phase 1/2 clinical trial approved for initiation 2 pages 180.3KB Regulatory Filings	2024-05-19	English
CHM CORE-NK vactosertib Phase 1b study re-opens enrolment 2 pages 203.1KB Regulatory Filings	2024-05-15	English
Notice of Extraordinary General Meeting/Proxy Form 25 pages 617.6KB Proxy Solicitation & Information Statement	2024-05-12	English
Notification regarding unquoted securities - CHM 6 pages 18.8KB Share Issue/Capital Change	2024-05-12	English
Dr Rebecca McQualter appointed COO 3 pages 240.1KB Board/Management Information	2024-05-01	English
Application for quotation of securities - CHM 6 pages 18.5KB Share Issue/Capital Change	2024-05-01	English
Notice under section 708A 1 page 215.1KB Share Issue/Capital Change	2024-05-01	English
Resignation of CEO and Managing Director 2 pages 179.8KB Board/Management Information	2024-04-30	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 1.7MB Interim / Quarterly Report	2024-04-29	English
Change of Director's Interest Notice PH 3 pages 232.0KB Director's Dealing	2024-04-07	English
Change of Director's Interest Notice PH 2 pages 203.3KB Director's Dealing	2024-04-07	English
US patent allowed for CHM 0201 (CORE-NK) technology 2 pages 182.1KB Regulatory Filings	2024-04-04	English
Notification of cessation of securities - CHM 4 pages 14.8KB Share Issue/Capital Change	2024-04-01	English
Application for quotation of securities - CHM 6 pages 18.6KB Share Issue/Capital Change	2024-03-27	English
Notice under section 708A 1 page 215.2KB Regulatory Filings	2024-03-27	English
Chimeric to present at NWR Virtual Healthcare Conference 2 pages 183.1KB Investor Presentation	2024-03-14	English
Clinical milestones for 2024 & 2023 successes highlighted 5 pages 289.2KB Capital/Financing Update	2024-03-13	English
Notification of cessation of securities - CHM 4 pages 15.5KB Regulatory Filings	2024-03-06	English
Half Yearly Report and Accounts 48 pages 2.1MB Interim / Quarterly Report	2024-02-28	English
Notice under section 708A 1 page 215.7KB Regulatory Filings	2024-02-28	English
Chimeric to present at ShareCafe Hidden Gems webinar 2 pages 181.1KB Investor Presentation	2024-02-27	English
Application for quotation of securities - CHM 6 pages 18.6KB Share Issue/Capital Change	2024-02-27	English
Late lodgement of Appendix 3Y 3 pages 368.0KB Director's Dealing	2024-02-14	English
1st patient treated in ADVENT-AML Phase 1b clinical trial 2 pages 207.8KB Regulatory Filings	2024-02-07	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 382.9KB Interim / Quarterly Report	2024-01-30	English
Application for quotation of securities - CHM 6 pages 27.8KB Capital/Financing Update	2024-01-23	English
Placement of Entitlement Offer Shortfall 3 pages 215.5KB Capital/Financing Update	2024-01-17	English
Investor Presentation 41 pages 9.3MB Investor Presentation	2024-01-17	English
ADVENT-AML Phase 1B clinical trial open to enrolment 3 pages 209.5KB Regulatory Filings	2024-01-14	English
CHIMERIC RECEIVES $7.36M R&D TAX INCENTIVE 2 pages 182.4KB Capital/Financing Update	2024-01-09	English
Application for quotation of securities - CHM 6 pages 28.4KB Share Issue/Capital Change	2024-01-04	English
Notification regarding unquoted securities - CHM 7 pages 29.6KB Capital/Financing Update	2024-01-04	English
Notice Under Section 708A 1 page 215.1KB Capital/Financing Update	2024-01-04	English
CHM Secures Further $1M Investment 2 pages 208.8KB Capital/Financing Update	2024-01-03	English
Proposed issue of securities - CHM 5 pages 27.1KB Capital/Financing Update	2024-01-03	English
Proposed issue of securities - CHM 5 pages 27.0KB Capital/Financing Update	2024-01-03	English